Experience with Denosumab (XGEVA®) for Prevention of Skeletal-Related Events in the 10 Years after Approval
Journal of bone oncology（2022）
Key words
Denosumab,Bone metastasis,Skeletal-related events,Efficacy,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined